![](/img/cover-not-exists.png)
Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: The Oral Rapamune to Inhibit Restenosis (ORBIT) study
Ron Waksman, Andrew E. Ajani, Augusto D. Pichard, Rebecca Torguson, Ellen Pinnow, Daniel Canos, Lowell F. Satler, Kenneth M. Kent, Pramod Kuchulakanti, Chrysoula Pappas, Louise Gambone, Neil Weissman,Volume:
44
Year:
2004
Language:
english
DOI:
10.1016/j.jacc.2004.06.069
File:
PDF, 105 KB
english, 2004